Title 19 Promis bought PMN
July 29, 2025 · Form 4 insider transaction
Title 19 Promis bought 539,100 shares of ProMIS Neurosciences, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
539,100
Price
N/A
Total value
N/A
InsiderTitle 19 Promis
Role—
SecurityWarrants to Purchase Common Shares
Transaction codeP: Open-market purchase
Transaction dateJuly 29, 2025
Filing dateJuly 29, 2025
Shares owned after539,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 29, 2025, Title 19 Promis acquired 539,100 warrants, each exercisable to purchase one Common Share, at an exercise price of $1.25 per share. The purchase price for each warrant was $0.1875 per share. The warrants are currently exercisable and expire five years after the date of issuance.